TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer.

Martin Scurr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.